258 related articles for article (PubMed ID: 17217540)
1. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
Fulford LG; Reis-Filho JS; Ryder K; Jones C; Gillett CE; Hanby A; Easton D; Lakhani SR
Breast Cancer Res; 2007; 9(1):R4. PubMed ID: 17217540
[TBL] [Abstract][Full Text] [Related]
2. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
3. BRCA-mutated Invasive Breast Carcinomas: Immunohistochemical Analysis of Insulin-like Growth Factor II mRNA-binding Protein (IMP3), Cytokeratin 8/18, and Cytokeratin 14.
Mohanty SK; Lai JP; Gordon OK; Pradhan D; Bose S; Dadmanesh F
Breast J; 2015; 21(6):596-603. PubMed ID: 26390986
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
[TBL] [Abstract][Full Text] [Related]
5. Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer.
Umekita Y; Ohi Y; Souda M; Rai Y; Sagara Y; Sagara Y; Tamada S; Tanimoto A
Diagn Pathol; 2011 Apr; 6():36. PubMed ID: 21496280
[TBL] [Abstract][Full Text] [Related]
6. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin profiles of male breast cancers.
Ciocca V; Bombonati A; Gatalica Z; Di Pasquale M; Milos A; Ruiz-Orrico A; Dreher D; Folch N; Monzon F; Santeusanio G; Perou CM; Bernard PS; Palazzo JP
Histopathology; 2006 Oct; 49(4):365-70. PubMed ID: 16978199
[TBL] [Abstract][Full Text] [Related]
8. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.
Jones C; Nonni AV; Fulford L; Merrett S; Chaggar R; Eusebi V; Lakhani SR
Br J Cancer; 2001 Aug; 85(3):422-7. PubMed ID: 11487275
[TBL] [Abstract][Full Text] [Related]
9. [Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].
Mainka P; Kahlert S; Kirchner T; Mayr D; Diebold J
Pathologe; 2008 Nov; 29 Suppl 2():363-9. PubMed ID: 18807040
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes.
Jones C; Ford E; Gillett C; Ryder K; Merrett S; Reis-Filho JS; Fulford LG; Hanby A; Lakhani SR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5988-97. PubMed ID: 15447982
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 7 negative invasive breast carcinoma: clinicopathological and immunohistochemical analysis of 14 cases with clinical follow-up.
Moatamed NA; Wu A; Sarah K; Apple SK
J Clin Pathol; 2015 Jun; 68(6):484-7. PubMed ID: 25710705
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of basal cytokeratin expression in breast cancer.
Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
[TBL] [Abstract][Full Text] [Related]
13. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
Fulford LG; Easton DF; Reis-Filho JS; Sofronis A; Gillett CE; Lakhani SR; Hanby A
Histopathology; 2006 Jul; 49(1):22-34. PubMed ID: 16842243
[TBL] [Abstract][Full Text] [Related]
14. Basal markers and prognosis in luminal breast cancer.
Engstrøm MJ; Valla M; Bofin AM
Breast Cancer Res Treat; 2017 Jun; 163(2):207-217. PubMed ID: 28258354
[TBL] [Abstract][Full Text] [Related]
15. The cytokeratin profile of medullary carcinoma of the breast.
Tot T
Histopathology; 2000 Aug; 37(2):175-81. PubMed ID: 10931242
[TBL] [Abstract][Full Text] [Related]
16. Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis.
Yu L; Yang W; Cai X; Shi D; Fan Y; Lu H
Histopathology; 2010 Aug; 57(2):193-201. PubMed ID: 20716161
[TBL] [Abstract][Full Text] [Related]
17. [Basal-like breast cancers: clinicopathological features and outcome].
De Brot M; Soares FA; Stiepcich MM; Cúrcio VS; Gobbi H
Rev Assoc Med Bras (1992); 2009; 55(5):529-34. PubMed ID: 19918651
[TBL] [Abstract][Full Text] [Related]
18. The influence of basal phenotype on the metastatic pattern of breast cancer.
Luck AA; Evans AJ; Green AR; Rakha EA; Paish C; Ellis IO
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):40-5. PubMed ID: 17981444
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
20. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
